ArticleCurrent medical science2026

ATF6 Identification Sensitizes B-Cell Precursor Acute Lymphoblastic Leukemia Cells to Doxorubicin.

Samira Rahimi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.